YOLFTbeta
Hofseth Biocare ASA

Hofseth Biocare ASA

HBC · OL · Consumer Defensive / Packaged Foods

1.12NOK+0.00 (+0.45%)

Price History

Full chart

Market Stats

Previous Close1.11
Open1.10
Day Range1.10 – 1.12
52-Week Range1.10 – 2.10
Volume52.03K
Market Cap673.29M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.34
Dividend Yield0.00%
Beta0.27
50-Day Avg1.34
200-Day Avg1.34

About

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Jon Olav Odegard
  • Employees78
  • HeadquartersKeiser Wilhelms gate 24, Ålesund, Norway, 6003, Norway
  • Websitehttps://www.hofsethbiocare.com

Leadership

  • Mr. Jon Olav OdegardChief Executive Officer
  • Dr. Bomi Framroze Ph.D.Chief Scientific Officer · b. 1961
  • Mr. James BergerChief Commercial Officer
  • Ms. Angelika FlorvaagChief Quality Officer
  • Dr. Crawford Linden Alexander Currie M.B.A., M.D.Head of Medical R&D and Director
  • Mr. Leif Arne GiskeChief Financial Officer
  • Mr. Magnus HavnenHead of Supply Chain
  • Mr. Tom JamesHead of Manufacturing
  • Mr. Paul BruhnHead of New Business Development & Director

Financials

Income Statement

Currency: NOK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue171.00K1.18M26.02M62.94M19.77M55.14M20.20M118.48M60.74M67.78M69.25M87.62M120.45M194.87M257.42M256.34M
Growth (%)-+591.81%+2099.07%+141.92%-68.59%+178.91%-63.36%+486.40%-48.73%+11.59%+2.17%+26.52%+37.47%+61.79%+32.09%-0.42%
Cost of Revenue-462.00K23.96M25.31M14.62M65.37M101.41M54.93M48.36M59.57M39.53M64.52M91.93M150.69M169.55M160.97M
Gross Profit171.00K721.00K2.05M37.62M5.15M-10.24M-81.20M63.55M12.38M8.21M29.72M23.10M28.51M44.19M87.86M95.37M
Gross Margin100.00%60.95%7.89%59.78%26.05%-18.56%-401.93%53.64%20.38%12.11%42.92%26.36%23.67%22.67%34.13%37.21%
Operating Expense13.08M25.04M60.10M85.11M68.37M83.11M63.36M74.74M90.08M87.78M121.74M141.66M157.13M146.72M201.85M207.72M
Operating Income-12.90M-24.32M-58.04M-47.49M-63.22M-93.34M-144.56M-11.20M-77.70M-79.57M-92.02M-118.56M-128.62M-102.53M-113.98M-112.35M
Operating Margin-7546.78%-2055.71%-223.12%-75.45%-319.78%-169.30%-715.52%-9.45%-127.92%-117.40%-132.88%-135.32%-106.78%-52.61%-44.28%-43.83%
EBITDA-12.83M-22.62M-50.02M-32.52M-44.60M-74.28M-118.54M8.54M-58.51M-55.49M-69.07M-87.72M-97.01M-62.73M-68.01M-72.55M
EBITDA Margin-7502.34%-1912.26%-192.28%-51.67%-225.59%-134.72%-586.71%7.20%-96.33%-81.87%-99.73%-100.12%-80.54%-32.19%-26.42%-28.30%
Net Income-9.39M-19.04M-73.86M-52.14M-66.92M-100.19M-147.45M-16.48M-84.77M-89.21M-102.09M-126.46M-137.39M-106.68M-123.41M-134.88M
Net Income Margin-5489.47%-1609.13%-283.91%-82.84%-338.50%-181.72%-729.81%-13.91%-139.56%-131.62%-147.42%-144.34%-114.06%-54.74%-47.94%-52.62%
R&D---1.69M2.82M4.38M1.79M1.30M2.43M131.00K7.56M12.53M13.63M11.01M14.98M12.40M
R&D as % of Total Revenue---2.69%14.28%7.93%8.85%1.09%4.00%0.19%10.92%14.30%11.32%5.65%5.82%4.84%
Interest Expense131.00K1.44M5.06M5.63M7.07M9.39M10.35M3.32M3.83M8.57M9.21M9.39M9.95M7.54M15.69M22.83M
Interest Expense % of Total Revenue76.61%121.30%19.47%8.94%35.75%17.03%51.22%2.80%6.31%12.65%13.31%10.72%8.26%3.87%6.09%8.91%

Balance Sheet

Currency: NOK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets94.56M158.37M155.64M205.05M217.87M193.35M159.35M184.24M187.94M293.01M459.13M415.97M411.03M390.12M341.37M394.27M
Total Liabilities18.59M37.84M107.92M143.05M138.92M160.80M105.79M147.16M101.90M175.26M195.37M275.60M263.00M348.98M280.07M469.12M
Total Equity75.97M120.45M48.31M62.62M79.59M33.19M54.22M37.75M86.72M118.43M264.45M141.06M148.72M41.83M60.05M-74.84M
Cash2.51M18.55M1.50M3.14M1.79M27.48M15.16M40.67M48.64M93.21M170.71M47.21M29.88M23.89M25.58M63.28M
Total Debt8.43M23.57M68.53M96.86M100.41M98.62M74.44M81.43M58.30M135.44M100.84M139.18M104.17M280.79M170.88M-
Net Debt5.92M5.02M67.03M93.72M98.63M71.14M59.29M40.76M9.66M42.23M-69.87M91.97M74.29M259.92M145.30M191.42M

Cash Flow

Currency: NOK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-12.45M-19.47M-48.01M-83.65M-62.26M7.97M-67.23M-25.48M-28.63M-31.06M-61.63M-61.78M-45.17M2.76M-9.78M-27.81M
Investing Cash Flow-19.78M-30.13M-17.41M-13.32M-10.32M-12.37M-42.10M63.51M-9.84M-27.17M-60.06M-37.94M-17.78M-14.99M-4.07M-20.46M
Financing Cash Flow33.92M65.63M49.10M98.67M71.18M30.74M96.62M-12.12M45.03M96.58M199.97M-23.20M45.45M3.70M15.58M91.50M
Capital Expenditure24.20M29.53M17.11M26.97M10.05M11.84M42.59M13.80M9.84M28.80M54.46M37.75M17.78M8.19M4.07M20.46M
Free Cash Flow-36.65M-49.00M-65.12M-110.62M-72.30M-3.87M-109.81M-39.29M-38.46M-59.86M-116.09M-99.53M-62.95M-11.30M-13.89M-41.65M
FCF to OCF294.49%251.67%135.64%132.24%116.14%-48.58%163.35%154.15%134.37%192.73%188.36%161.11%139.36%-409.31%142.03%149.80%

Earnings

Report DateFeb 29, 2012May 25, 2012Aug 29, 2012Oct 31, 2012Feb 28, 2013May 30, 2013Aug 28, 2013Nov 11, 2013Feb 26, 2014May 28, 2014Aug 28, 2014Nov 13, 2014Feb 25, 2015May 28, 2015Aug 21, 2015Nov 13, 2015Feb 18, 2016May 20, 2016Aug 19, 2016Nov 18, 2016Feb 15, 2017May 11, 2017Aug 25, 2017Nov 15, 2017Feb 15, 2018May 9, 2018Aug 24, 2018Nov 2, 2018Feb 8, 2019May 30, 2019Aug 30, 2019Nov 1, 2019Feb 7, 2020May 15, 2020Aug 28, 2020Oct 30, 2020Feb 5, 2021May 21, 2021Aug 27, 2021Nov 5, 2021Feb 4, 2022May 20, 2022Aug 26, 2022Nov 11, 2022Feb 10, 2023May 12, 2023Aug 25, 2023Nov 10, 2023Jan 4, 2024May 10, 2024Aug 23, 2024Nov 8, 2024Feb 14, 2025May 9, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-0.06-0.08--0.06-0.03---0.13---0.20-0.09-0.14--0.060.080.18------------------------------------------
EPS Actual-0.12-0.24-0.17-0.12-0.28-0.27-0.22-0.11-0.01-0.17-0.13-0.16-0.29-0.19-0.23-0.13-0.16-0.25-0.43-0.36-0.070.12-0.08-0.05-0.06-0.09-0.08-0.07-0.08-0.07-0.06-0.06-0.08-0.05-0.06-0.10-0.09-0.07-0.07-0.11-0.10-0.10-0.08-0.09-0.10-0.100.01-0.06-0.13-0.07-0.04-0.09-0.10-0.08-0.06-0.07-0.12-0.09-0.06
Surprise-100.00%-200.00%--100.00%-833.33%--15.38%--35.00%-77.78%-107.14%--283.33%-262.50%-188.89%------------------------------------------
TimingPre-marketPre-market--After-hours---Pre-market--After-hoursAfter-hours--Pre-marketPre-market---After-hoursAfter-hoursAfter-hoursAfter-hoursPre-market---------------Pre-marketPre-market------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap673.29M
Enterprise Value871.00M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales2.78
Price / Book676.61
EPS-0.34
Book Value-0.059
Revenue (TTM)242.20M
Gross Profit (TTM)73.83M
EBITDA-98.63M
Profit Margin-56.38%
Operating Margin-19.60%
Return on Equity-346.49%
Return on Assets-17.57%
Shares Outstanding506.23M
Shares Float144.58M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 16, 20201155:1151